These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 28297773

  • 1. [Establishment and evaluation of noninvasive diagnostic models for liver fibrosis in patients with chronic hepatitis B].
    Yang Q, Liu DP, Li LP, Gu Y, Zhang MX, Liu Y, Yang K.
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jan 20; 25(1):15-20. PubMed ID: 28297773
    [Abstract] [Full Text] [Related]

  • 2. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL, Xiao YQ, Chen F.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan 20; 17(1):28-32. PubMed ID: 19203448
    [Abstract] [Full Text] [Related]

  • 3. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
    Liu XD, Wu JL, Liang J, Zhang T, Sheng QS.
    World J Gastroenterol; 2012 Jun 14; 18(22):2784-92. PubMed ID: 22719186
    [Abstract] [Full Text] [Related]

  • 4. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.
    Zeng X, Xu C, He D, Li M, Zhang H, Wu Q, Xiang D, Wang Y.
    Croat Med J; 2015 Jun 14; 56(3):272-9. PubMed ID: 26088852
    [Abstract] [Full Text] [Related]

  • 5. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
    Zhou QQ, Hu YB, Zhou K, Zhang WW, Li MH, Dong P, Di JG, Hong L, Du QW, Xie Y, Sun QF.
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep 20; 24(9):665-670. PubMed ID: 27788722
    [Abstract] [Full Text] [Related]

  • 6. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
    Liu DP, Lu W, Zhang ZQ, Wang YB, Ding RR, Zhou XL, Huang D, Li XF.
    J Viral Hepat; 2018 May 20; 25(5):581-589. PubMed ID: 29230907
    [Abstract] [Full Text] [Related]

  • 7. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC, Liu H, Liu XY, Ma LN, Guan YH, Luo X, Ding XC.
    World J Gastroenterol; 2017 Nov 07; 23(41):7425-7432. PubMed ID: 29151696
    [Abstract] [Full Text] [Related]

  • 8. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
    Li Q, Song J, Huang Y, Li X, Zhuo Q, Li W, Chen C, Lu C, Qi X, Chen L.
    Medicine (Baltimore); 2016 Apr 07; 95(16):e3372. PubMed ID: 27100421
    [Abstract] [Full Text] [Related]

  • 9. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
    Zeng DW, Dong J, Jiang JJ, Zhu YY, Liu YR.
    World J Gastroenterol; 2016 Nov 21; 22(43):9586-9594. PubMed ID: 27920479
    [Abstract] [Full Text] [Related]

  • 10. [Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B].
    Liang CF, Chang YN, Peng XR, He Y, Chen M, Peng ML, Hu P, Ren H, Xu HM.
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jun 20; 29(6):551-557. PubMed ID: 34225430
    [Abstract] [Full Text] [Related]

  • 11. Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B.
    Liu D, Li J, Lu W, Wang Y, Zhou X, Huang D, Li X, Ding R, Zhang Z.
    Clin Microbiol Infect; 2019 Apr 20; 25(4):514.e1-514.e8. PubMed ID: 29906588
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The prediction and validation of liver fibrosis by a noninvasive model and validation in patients with chronic hepatitis B].
    Liu WP, Xu DJ, Zhao LR, Lu ZH, Wang YH, Lang ZW, Wang GQ.
    Zhonghua Nei Ke Za Zhi; 2008 Apr 20; 47(4):308-12. PubMed ID: 18843956
    [Abstract] [Full Text] [Related]

  • 17. The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients.
    Coskun BD, Altinkaya E, Sevinc E, Ozen M, Karaman H, Karaman A, Poyrazoglu O.
    Rev Esp Enferm Dig; 2015 Dec 20; 107(12):740-4. PubMed ID: 26671586
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection.
    Ma J, Jiang Y, Gong G.
    Eur J Gastroenterol Hepatol; 2013 Apr 20; 25(4):428-34. PubMed ID: 23358121
    [Abstract] [Full Text] [Related]

  • 20. A novel noninvasive index for the prediction of moderate to severe fibrosis in chronic hepatitis B patients.
    Li J, Mao RC, Li XL, Zheng JW, Qi X, Yuan Q, Zhang J, Zhang JM, Xia NS.
    Dig Liver Dis; 2018 May 20; 50(5):482-489. PubMed ID: 29396134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.